薬物乱用治療の世界市場：タイプ別、治療タイプ別、年齢層別、治療環境別、地域別

薬物乱用治療の世界市場は、2025年には118億2,000万米ドルと推定され、2032年には213億3,000万米ドルに達すると予測され、2025年から2032年までのCAGRは8.8%で成長すると予測されます。

図.薬物乱用治療の世界市場シェア（%）、2025年地域別

薬物乱用治療とは、薬物依存を管理し、長期的な断酒と回復を支援することを目的としたプログラムと活動を指します。中毒としても知られる物質乱用障害は、有害で中毒性のある物質を、その悪影響にもかかわらず、強迫的または制御不能に使用することを含みます。一般的な乱用物質には、アルコール、オピオイド、大麻、コカイン、覚醒剤などがあります。薬物乱用障害の主な徴候には、摂取量を減らすことができない、欲求を経験する、使用していないときに禁断症状が出るなどがあります。依存症に罹患している人は、しばしば自制心の低下、社会的問題、危険な使用、時には身体的依存を経験します。薬物乱用治療は、治療的介入、カウンセリング、薬物療法、地域支援プログラムを通じて、依存症の生物学的、心理学的、社会的、行動的側面に対処することを目的としています。世界の薬物乱用率の上昇が、効果的な治療オプションへの需要を煽っています。

市場力学：

世界の薬物乱用治療市場は、薬物乱用障害の有病率の上昇、治療の有効性に関する意識の高まり、有利な規制と償還政策、新規の薬物補助治療製品の発売によって牽引されています。しかし、依存症に関連する社会的スティグマ、低所得地域における治療施設へのアクセス不足、治療プロトコルのコンプライアンス違反などの問題により、市場の成長は抑制される可能性があります。デジタル治療ソリューションの開発、統合ケアモデル、特定の依存症に的を絞った治療、新興国市場への進出は、市場参入者にとって主なビジネスチャンスとなります。地域的には、北米が高度なヘルスケア・インフラと認知度により市場を独占しています。しかし、アジア太平洋地域は予測期間中に有利な成長が見込まれます。

本調査の主な特徴

• 当レポートでは、世界の薬物乱用治療市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスを解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する主要考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の薬物乱用治療市場の主要企業をプロファイルしています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の薬物乱用治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の薬物乱用治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
• 薬物とアルコールの消費量の増加
• 政府とNGOからの支援の拡大
  • 抑制要因
• 薬物依存に関連する社会的偏見
• 適切なリハビリ施設の不足
  • 機会
• 新興諸国の未開拓市場
• 企業の市場シェア分析
• 主なハイライト
• 市場動向
• PEST分析
• PORTERの分析
• 最近の製品承認/発売
• 合併、買収、および提携

第4章 世界の薬物乱用治療市場- コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の薬物乱用治療市場、タイプ別、2020年～2032年

• アルコール
• オピオイド（例：ヘロイン、処方鎮痛剤）
• タバコ/ニコチン
• コカイン
• マリファナ
• メタンフェタミン
• その他の違法薬物（ベンゾジアゼピンなど）

第6章 世界の薬物乱用治療市場、治療タイプ別、2020年～2032年

• オピオイド
• メサドン
• ブプレノルフィン
• 徐放性ナルトレキソン
• ロフェキシジン
• ニコチン
• ニコチン置換療法（パッチ、吸入器、ガムとして利用可能）
• ブプロピオン
• バレニクリン
• アルコール
• ナルトレキソン
• ジスルフィラム
• アカンプロサート
• タバコ
• クロニジン
• ノルトリプチリン
• その他（トピラマート、モダフィニルなど）

第7章 世界の薬物乱用治療市場、年齢グループ別、2020年～2032年

• 青少年
• 大人
• 高齢者

第8章 世界の薬物乱用治療市場、治療環境別、2020年～2032年

• 外来治療
• 外来診療所
• 個人診療所
• 入院治療
• リハビリテーションセンター
• 病院
• 住宅治療施設
• 解毒センター

第9章 世界の薬物乱用治療市場、地域別、2020年～2032年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東
• アフリカ

第10章 競合情勢

• 企業プロファイル
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson &Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

第11章 セクション

• 参考文献
• 調査手法
• 出版社について

Global Substance Abuse Treatment Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 21.33 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Global Substance Abuse Treatment Market Share (%), By Region 2025

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

• Global Substance Abuse Treatment Market, By Type
  • Alcohol
  • Opioids (e.g., heroin, prescription painkillers)
  • Tobacco/nicotine
  • Cocaine
  • Marijuana
  • Methamphetamines
  • Other illicit drugs (Benzodiazepines, etc.)
• Global Substance Abuse Treatment Market, By Treatment Type
  • Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
• Global Substance Abuse Treatment Market, By Age Group
  • Adolescents
  • Adults
  • Geriatric
• Global Substance Abuse Treatment Market, By Treatment Setting
  • Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
  • Detoxification Centers
• Global Substance Abuse Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Treatment Type
  • Market Snippet, By Age Group
  • Market Snippet, By Treatment Setting
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing consumption of drugs and alcohol
• Growing support from government and NGOs
  • Restraints
• Social stigma associated with substance dependence
• Lack of adequate rehabilitation facilities
  • Opportunities
• Untapped markets in developing countries
• Company Market Share Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Opioids (e.g., heroin, prescription painkillers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tobacco/nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cocaine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Marijuana
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methamphetamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other illicit drugs (Benzodiazepines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methadone
• Buprenorphine
• Extended-release naltrexone
• Lofexidine
• Nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nicotine replacement therapies (available as a patch, inhaler, or gum)
• Bupropion
• Varenicline
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Naltrexone
• Disulfiram
• Acamprosate
• Tobacco
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clonidine
• Nortriptyline
• Others (Topiramate, Modafinil, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Outpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Outpatient Clinics
• Private Practices
• Inpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Rehabilitation Centers
• Hospitals
• Residential Treatment Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Detoxification Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Indivior PLC
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us